These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 454940)

  • 1. Effect of cooling on efflux of [3H]-noradrenaline in canine cutaneous veins [proceedings].
    Janssens WJ; Vanhoutte PM
    Br J Pharmacol; 1979 May; 66(1):148P. PubMed ID: 454940
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):139-47. PubMed ID: 3014112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of moderate cooling on the overflow of endogenous and tritiated norepinephrine in canine saphenous veins.
    Janssens WJ; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):336-7. PubMed ID: 7406592
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of labetalol on the release of [3H]-labelled noradrenaline and its metabolites from dog isolated saphenous vein [proceedings].
    Drew GM; Levy GP; Sullivan AT
    Br J Pharmacol; 1979 May; 66(1):151P. PubMed ID: 454943
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of neuronal uptake in the disposition of released [3H]-noradrenaline in the dog's saphenous vein [proceedings].
    Vanhoutte PM; Verbeuren TJ
    Br J Pharmacol; 1979 May; 66(1):149P. PubMed ID: 454941
    [No Abstract]   [Full Text] [Related]  

  • 6. Depression by local cooling of 3H-norepinephrine release evoked by nerve stimulation in cutaneous veins.
    Vanhoutte PM; Verbeuren TJ
    Blood Vessels; 1976; 13(1-2):92-9. PubMed ID: 1247697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternation of contraction and relaxation during profound cooling in canine cutaneous veins [proceedings].
    Rusch NJ; Shepherd JT; Vanhoutte PM
    J Physiol; 1979 Oct; 295():74P-75P. PubMed ID: 521989
    [No Abstract]   [Full Text] [Related]  

  • 8. The endothelium inhibits the penetration of serotonin and norepinephrine in the isolated canine saphenous vein.
    Verbeuren TJ; Jordaens FH; Bult H; Herman AG
    J Pharmacol Exp Ther; 1988 Jan; 244(1):276-82. PubMed ID: 3336004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by acetylcholine of 3H-norepinephrine release in cutaneous veins after alpha-adrenergic blockade.
    Vanhoutte PM; Verbeuren TJ
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):344-6. PubMed ID: 9039
    [No Abstract]   [Full Text] [Related]  

  • 10. Moderate cooling depresses the accumulation and the release of newly synthesized catecholamines in isolated canine saphenous veins.
    Boels PJ; Verbeuren TJ; Vanhoutte PM
    Experientia; 1985 Nov; 41(11):1374-7. PubMed ID: 4065290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of neuronal uptake inhibitors on tissue accumulation of 3H-norepinephrine and its metabolites in isolated canine saphenous veins.
    Verbeuren TJ; Coen EP; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):314-5. PubMed ID: 7165439
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a high dose of prazosin, and transmural stimulation, on the disposition of transmitter noradrenaline in the rabbit pulmonary artery and the dog saphenous vein [proceedings].
    Anderson MJ; Cambridge D; Davey MJ; Massingham R
    Br J Pharmacol; 1979 May; 66(1):151P-152P. PubMed ID: 454944
    [No Abstract]   [Full Text] [Related]  

  • 13. Formation of 3H-dopamine and 3H-noradrenaline from 3H-tyrosine in the canine saphenous vein.
    Boels PJ; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1981 Oct; 253(2):315-16. PubMed ID: 7325767
    [No Abstract]   [Full Text] [Related]  

  • 14. A kinetic study of the ouabain-induced efflux of norepinephrine from the dog saphenous vein.
    Monteiro JG
    J Pharmacol Exp Ther; 1991 Jul; 258(1):311-6. PubMed ID: 2072302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine uptake in canine saphenous veins in the presence and absence of halothane.
    Hunter LW; Rorie DK; Tyce GM
    Anesth Analg; 1986 Apr; 65(4):360-4. PubMed ID: 3954109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of MAO-inhibitors on deamination of 3H-norepinephrine in the dog's saphenous vein.
    Verbeuren TJ; Vanhoutte PM
    Arch Int Pharmacodyn Ther; 1978 Apr; 232(2):348-9. PubMed ID: 677971
    [No Abstract]   [Full Text] [Related]  

  • 17. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
    Verbeuren TJ; Jordaens FH; Herman AG
    J Pharmacol Exp Ther; 1983 Aug; 226(2):579-88. PubMed ID: 6875866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of endogenous noradrenaline released by electrical stimulation in vitro of dog saphenous vein.
    Brandão F; Guimarães S
    Blood Vessels; 1974; 11(1-2):45-54. PubMed ID: 4447847
    [No Abstract]   [Full Text] [Related]  

  • 19. Alpha-1 and alpha-2 adrenoceptor: response coupling in canine saphenous and femoral veins.
    Flavahan NA; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jul; 238(1):131-8. PubMed ID: 3014111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yohimbine inhibits the potentiation by moderate cooling of norepinephrine-induced contractions of canine blood vessels.
    Janssens WJ; Verhaeghe RH
    Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):173-4. PubMed ID: 7092415
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.